Cargando…
Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978623/ https://www.ncbi.nlm.nih.gov/pubmed/24485167 http://dx.doi.org/10.1186/ar4372 |
_version_ | 1782310601564880896 |
---|---|
author | Gómez-Puerta, José A Celis, Raquel Hernández, M Victoria Ruiz-Esquide, Virginia Ramírez, Julio Haro, Isabel Cañete, Juan D Sanmartí, Raimon |
author_facet | Gómez-Puerta, José A Celis, Raquel Hernández, M Victoria Ruiz-Esquide, Virginia Ramírez, Julio Haro, Isabel Cañete, Juan D Sanmartí, Raimon |
author_sort | Gómez-Puerta, José A |
collection | PubMed |
description | INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines in patients with RA according to the presence or absence of ACPA in serum. METHODS: A cross-sectional study in a single center including consecutive RA patients was performed. Patients were defined as 'ACPA negative' if serum was negative to two different ACPAs [second generation commercial anti-cyclic citrullinated peptide antibodies (CCP2) and chimeric fibrin/filaggrin citrullinated antibodies]. Parallel synovial tissue (ST) biopsies and SF were obtained by knee arthroscopy. Synovial cell infiltrate and endothelial cells were analyzed by immunohistochemistry and SF levels of Th1, Th2, Th17 and pro-inflammatory cytokines by Quantibody(R) Human Array. RESULTS: A total of 83 patients underwent arthroscopy, with a mean age of 55.9 ± 12 years, and mean disease duration of 45 months (interquartile range, IQR 10.8 to 122). 62% were female and 77% were ACPA positive. No significant differences were found in clinical variables, acute phase reactants, synovial cell infiltrate or lymphoid neogenesis (LN) between ACPA positive and negative patients. However ACPA positive patients had significantly higher levels of IL-1β, IL-10, IL-17 F and CC chemokine ligand 20 (CCL-20) than ACPA negative patients. CONCLUSIONS: In our cohort of patients with RA no significant differences were found in synovial cell infiltrate or synovial LN according to ACPA status. However, ACPA positive patients had higher levels of T-cell derived and pro-inflammatory cytokines than ACPA negative patients. As systemic and local inflammation was similar in the two groups, these findings support a distinct synovial physiopathology. |
format | Online Article Text |
id | pubmed-3978623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39786232014-04-09 Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients Gómez-Puerta, José A Celis, Raquel Hernández, M Victoria Ruiz-Esquide, Virginia Ramírez, Julio Haro, Isabel Cañete, Juan D Sanmartí, Raimon Arthritis Res Ther Research Article INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines in patients with RA according to the presence or absence of ACPA in serum. METHODS: A cross-sectional study in a single center including consecutive RA patients was performed. Patients were defined as 'ACPA negative' if serum was negative to two different ACPAs [second generation commercial anti-cyclic citrullinated peptide antibodies (CCP2) and chimeric fibrin/filaggrin citrullinated antibodies]. Parallel synovial tissue (ST) biopsies and SF were obtained by knee arthroscopy. Synovial cell infiltrate and endothelial cells were analyzed by immunohistochemistry and SF levels of Th1, Th2, Th17 and pro-inflammatory cytokines by Quantibody(R) Human Array. RESULTS: A total of 83 patients underwent arthroscopy, with a mean age of 55.9 ± 12 years, and mean disease duration of 45 months (interquartile range, IQR 10.8 to 122). 62% were female and 77% were ACPA positive. No significant differences were found in clinical variables, acute phase reactants, synovial cell infiltrate or lymphoid neogenesis (LN) between ACPA positive and negative patients. However ACPA positive patients had significantly higher levels of IL-1β, IL-10, IL-17 F and CC chemokine ligand 20 (CCL-20) than ACPA negative patients. CONCLUSIONS: In our cohort of patients with RA no significant differences were found in synovial cell infiltrate or synovial LN according to ACPA status. However, ACPA positive patients had higher levels of T-cell derived and pro-inflammatory cytokines than ACPA negative patients. As systemic and local inflammation was similar in the two groups, these findings support a distinct synovial physiopathology. BioMed Central 2013 2013-11-07 /pmc/articles/PMC3978623/ /pubmed/24485167 http://dx.doi.org/10.1186/ar4372 Text en Copyright © 2013 Gómez-Puerta et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Gómez-Puerta, José A Celis, Raquel Hernández, M Victoria Ruiz-Esquide, Virginia Ramírez, Julio Haro, Isabel Cañete, Juan D Sanmartí, Raimon Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title | Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title_full | Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title_fullStr | Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title_full_unstemmed | Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title_short | Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
title_sort | differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978623/ https://www.ncbi.nlm.nih.gov/pubmed/24485167 http://dx.doi.org/10.1186/ar4372 |
work_keys_str_mv | AT gomezpuertajosea differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT celisraquel differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT hernandezmvictoria differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT ruizesquidevirginia differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT ramirezjulio differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT haroisabel differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT canetejuand differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients AT sanmartiraimon differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients |